Supernus Pharmaceuticals, Inc. v. Iancu, No. 17-1357 (Fed. Cir. Jan. 23, 2019)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Supernus Pharmaceuticals, Inc. and United Thera- peutics Corp. appeal the entry of summary judgment by the U.S. District Court for the Eastern District of Virgi n- ia. The district court determined that, based on this court’s decision in Gilead Sciences, Inc. v. Lee, the U.S. Patent and Trademark Office ’s calculation of the patent term adjustment for the patent at issue was correct, and that summary judgment was warranted as a matter of law.